The HIV+Hepatitis Policy Institute, a non-profit organization, is very grateful for support from individuals, foundations, and corporations that invest in our mission to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. The HIV and Hepatitis Policy Institute is a 501(c)(3) tax-exempt organization. Donations to HIV+Hep are tax-deductible to the full extent allowed by law.
If you are interested in making a donation, please contact: Carl Schmid, Executive Director, at cschmid@hivhep.org.
1602B Belmont Street NW | Washington DC 20009
Facebook posts by @HIV+Hep
We submitted questions to @SenFinance for @DrOz confirmation hearing, including if admin. will comply with Court ruling that #allcopayscount for #patients, uphold #ACA patient protections, & make sure #insurers cover #PrEP w/o #costsharing: bit.ly/42LafiR
HIV and Hepatitis Policy Institute’s Zach Lynkiewicz testified before MD’s Senate Finance Comm. in opposition to a bill seeking to expand PDAB authority w/o lowering #Rx costs for #patients w/#HIV & other chronic diseases, warning it could limit access & hinder new Rx development: bit.ly/40RCbib
Health clinics grapple with US funding squeeze
www.reuters.com
Some had to close or lay off staff. Others lost grants for HIV prevention.
In POZ Magazine Carl Schmid on the work of the U.S. Business Action to End #HIV: “A coalition like this is really crucial right now. A business-oriented message resonates with certain people, particularly at this time”:
U.S. Businesses Seek to Accelerate the Movement to End HIV
bit.ly
Nearly 70 companies are addressing the virus within and beyond their own walls.
Biden Rule Cleared Hurdles to Lifesaving HIV Drug, but in Georgia Barriers Remain:
Biden Rule Cleared Hurdles to Lifesaving HIV Drug, but in Georgia Barriers Remain - KFF Health News
kffhealthnews.org
A new rule requires insurers to improve coverage of PrEP, which can prevent HIV, but Georgians face challenges getting the drug.